End-of-day quote
Shanghai S.E.
23:00:00 27/06/2024 BST
|
5-day change
|
1st Jan Change
|
48.1
CNY
|
+1.16%
|
|
-10.48%
|
-9.16%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,907
|
4,026
|
9,532
|
6,069
|
9,835
|
8,934
|
-
|
-
|
Enterprise Value (EV)
1 |
3,907
|
4,026
|
9,532
|
6,069
|
9,835
|
8,934
|
8,934
|
8,934
|
P/E ratio
|
52.3
x
|
36.3
x
|
55.2
x
|
32.2
x
|
56.3
x
|
38.8
x
|
30.1
x
|
23.9
x
|
Yield
|
1.1%
|
1.07%
|
0.55%
|
-
|
0.94%
|
0.69%
|
0.94%
|
0.98%
|
Capitalization / Revenue
|
12.4
x
|
9.96
x
|
15.3
x
|
9.17
x
|
13.8
x
|
9.95
x
|
8.07
x
|
6.68
x
|
EV / Revenue
|
12.4
x
|
9.96
x
|
15.3
x
|
9.17
x
|
13.8
x
|
9.95
x
|
8.07
x
|
6.68
x
|
EV / EBITDA
|
-
|
28.7
x
|
43.3
x
|
-
|
40.1
x
|
27.3
x
|
22.3
x
|
17.8
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
4.36
x
|
4.18
x
|
8.72
x
|
4.93
x
|
7.3
x
|
5.88
x
|
5.05
x
|
4.36
x
|
Nbr of stocks (in thousands)
|
185,746
|
185,746
|
185,746
|
185,746
|
185,746
|
185,746
|
-
|
-
|
Reference price
2 |
21.04
|
21.68
|
51.32
|
32.67
|
52.95
|
48.10
|
48.10
|
48.10
|
Announcement Date
|
27/02/20
|
23/02/21
|
27/02/22
|
27/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
315.3
|
404.2
|
624.7
|
662
|
711.7
|
898.2
|
1,107
|
1,337
|
EBITDA
1 |
-
|
140.2
|
220.2
|
-
|
245
|
327
|
400
|
501
|
EBIT
1 |
85.13
|
123.9
|
197.2
|
190.2
|
195.4
|
258.4
|
331.6
|
418.5
|
Operating Margin
|
27%
|
30.65%
|
31.57%
|
28.73%
|
27.45%
|
28.77%
|
29.94%
|
31.3%
|
Earnings before Tax (EBT)
1 |
86.83
|
128.4
|
197.4
|
193.2
|
197.4
|
261
|
334.4
|
421.2
|
Net income
1 |
74.69
|
110.9
|
172.9
|
188.2
|
174
|
230.1
|
297
|
374
|
Net margin
|
23.69%
|
27.44%
|
27.67%
|
28.44%
|
24.45%
|
25.62%
|
26.82%
|
27.98%
|
EPS
2 |
0.4022
|
0.5971
|
0.9303
|
1.013
|
0.9400
|
1.240
|
1.600
|
2.012
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2314
|
0.2314
|
0.2814
|
-
|
0.5000
|
0.3300
|
0.4500
|
0.4700
|
Announcement Date
|
27/02/20
|
23/02/21
|
27/02/22
|
27/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
19.2%
|
12%
|
16.9%
|
16.3%
|
13.6%
|
14.9%
|
16.9%
|
18.1%
|
ROA (Net income/ Total Assets)
|
-
|
10.5%
|
14.4%
|
-
|
13.5%
|
11.8%
|
13.1%
|
13.9%
|
Assets
1 |
-
|
1,058
|
1,199
|
-
|
1,289
|
1,944
|
2,274
|
2,687
|
Book Value Per Share
2 |
4.820
|
5.190
|
5.890
|
6.620
|
7.250
|
8.180
|
9.530
|
11.00
|
Cash Flow per Share
2 |
0.4300
|
0.4800
|
0.8300
|
1.300
|
1.330
|
1.030
|
1.450
|
1.830
|
Capex
1 |
60.3
|
124
|
208
|
155
|
52.9
|
144
|
139
|
114
|
Capex / Sales
|
19.14%
|
30.7%
|
33.27%
|
23.39%
|
7.44%
|
16.03%
|
12.51%
|
8.53%
|
Announcement Date
|
27/02/20
|
23/02/21
|
27/02/22
|
27/02/23
|
22/02/24
|
-
|
-
|
-
|
Last Close Price
48.1
CNY Average target price
53
CNY Spread / Average Target +10.19% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.16% | 1.23B | | +0.73% | 99.64B | | -11.98% | 58.77B | | +75.71% | 48.81B | | +5.26% | 34.94B | | +3.47% | 18.62B | | +17.33% | 17.44B | | +5.92% | 13.51B | | -6.67% | 12.73B | | -25.86% | 12.04B |
Other Commodity Chemicals
|